- General information enquiries
- Call 00 800 6 7 8 9 10 11
- E-mail your questions
European Commission
Public Health
Accessibility tools
Service tools
Language selector
- Current languageen
Navigation path
- European Commission
- Public health
- Reference documents
- Register
- Orphan products
- (S)-2-(1-((6-amino-5-cyanopyrimidin-4-yl)amino)ethyl)-4-oxo-
Pharmaceuticals - Community Register
Community register of orphan medicinal products | GRANTED |
Product information |
(S)-2-(1-((6-amino-5-cyanopyrimidin-4-yl)amino)ethyl)-4-oxo-3-phenyl-3,4-dihydropyrrolo[2,1-f][1,2,4]triazine-5-carbonitrile
| EU orphan designation number: | EU/3/14/1335
|
| Active ingredient: | (S)-2-(1-((6-amino-5-cyanopyrimidin-4-yl)amino)ethyl)-4-oxo-3-phenyl-3,4-dihydropyrrolo[2,1-f][1,2,4]triazine-5-carbonitrile |
| Indication: | Treatment of pemphigus |
| Sponsor: | Almirall, S.A.
Ronda General Mitre, 151, E-08022 Barcelona, España |
Public summary of scientific opinion
European Commission procedures |
| Close date procedure | Procedure type | EMEA number | Decision | summary publ | decision docs | annex |
| 17/10/2014 | Orphan designation | EMA/OD/091/14 | (2014)7634 of 15/10/2014 |
CONTACT
EU links
Directorate General Health & Consumers